Agenda

We would like to thank our exhibitors for sponsoring this meeting, which includes pharmaceutical companies. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

*Please note this is a working agenda and sessions are subject to change. 

Wednesday, June 25, 2025
9:30 AM - 10:25 AM
Chair’s opening remark's followed by: Bag to bedside: IV fluid essentials
  • Types of IV fluids and indications 
  • Administering medications 
  • Monitoring and adjusting therapy 
  • Special populations and considerations 
  • Pharmacist as a key contributor 
 
 
10:40 AM - 11:25 AM
Fluid Stewardship at East Lancashire Hospitals – what we did and why
  • Why implement a Fluid Stewardship programme?
  • Pre implementation survey
  • Setting up Multi-disciplinary Team
Sponsored by Baxter Healthcare UK Ltd
Fluid Stewardship at East Lancashire Hospitals – what we did and why
11:40 AM - 12:25 PM
Licensed ready-to-use and ready-to-administer IV products – Can we put a price on safety?
  • Understand the differences between RTU and RTA IV products 
  • Evaluate the effect of RTU and RTA products on medication safety and the efficiency of administration 
  • Explore cost-benefit considerations related to RTU and RTA IV medicines 
  • Identify challenges in the implementation of RTU and RTA products in clinical practice 
  • Discuss real-world example(s) of improved patient safety through RTU and RTA adoption
 
 
12:40 PM - 1:25 PM
Transitioning to NRFit™ – Where are we now, and what can we do to manage patient safety risks?
  • Describe the purpose and design of NRFit™ 
  • Assess the current progress of NRFit™ adoption in clinical settings 
  • Identify possible safety risks related to neuraxial and regional anaesthesia connectors 
  • Discuss effective strategies for a smooth transition to NRFit™ in healthcare facilities 
  • Explore methods for training pharmacists on NRFit™ implementation 

 

 
 
1:40 PM - 2:25 PM
Shared Responsibility: Enhancing Occupational Safety Through Pharmacist–Nurse Collaboration
 
Sponsored by:
Shared Responsibility: Enhancing Occupational Safety Through Pharmacist–Nurse Collaboration
2:40 PM - 3:25 PM
Complications of IV therapy – CLABSI, thrombophlebitis and extravasation updates
  • Define CLABSI, thrombophlebitis and extravasation 
  • Identify risk factors contributing to IV therapy complications 
  • Review the latest guidelines and recommendations for preventing and managing these complications 
  • Discuss the role of pharmacists in early recognition and intervention 
  • Practical evidence/case study that highlights recent advancements in IV therapy safety 
 
 
3:40 PM - 4:25 PM
Initiatives in IV safety – what are we doing in the NHS to drive innovation and improvement?
  • Examine key NHS initiatives aimed at improving IV medication safety 
  • Assess the impact of technological innovations in IV therapy administration 
  • Discuss strategies for reducing medication errors and enhancing patient safety 
  • Explore the role of policy changes and national standards in shaping IV safety practices 
  • Identify opportunities for collaboration and further improvements in IV safety 
 
 

If you are interested in speaking at this event, please contact Lisa Thomlinson, Events Director.

If you are interested in sponsoring a talk on the Agenda, or exhibiting at the event, please contact Ed Burkle, Sales Director.